Bauer Highlights Assault on Faith in Strategic Ad Campaign in Iowa and Ohio
Bauer Highlights Assault on Faith in Strategic Ad Campaign in Iowa and Ohio
Filed under: Drug Rehab Centers Washington D.C.
WASHINGTON, Oct. 2, 2012 /PRNewswire-USNewswire/ — Former presidential candidate Gary Bauer announced this week that his Campaign for American Values… Continue reading
FDA ISSUES SAFETY ALERT on INTESTINOMICINA, DRUG PRODUCT …
FDA ISSUES SAFETY ALERT ON INTESTINOMICINA, DRUG PRODUCT …
Filed under: drug treatment programs washington dc
September 22, 2012 (Washington, D.C.) — The U.S. Food and Drug Administration is warning consumers not to use Intestinomicina, a drug product manufactured in… Continue reading
Humira Approved Treat Ulcerative Colitis
Humira Approved Treat Ulcerative Colitis
Filed under: Washington D.C. Drug Use
The U.S. Food and Drug Administration expanded the approved use of Humira (adalimumab) to include treatment of moderate-to-severe ulcerative colitis in adults. Washington, D.C. – infoZine – Humira is… Continue reading
FDA Approves Drug Formulated for Kids With Rare Brain Tumors
FDA Approves Drug Formulated for Kids with Rare Brain Tumors
Filed under: Drug Rehab Centers District of Columbia
WASHINGTON, D.C. (8/30/12) – The U.S. Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric… Continue reading
J&J's Janssen Unit Announces $181 Mln Settlement in Deceptive Marketing Case
J&J's Janssen Unit Announces 1 Mln Settlement In Deceptive Marketing Case
Filed under: District of Columbia Drug Use
The company will pay about $ 181 million, an amount which has been previously accrued, as part of a consent decree to… Continue reading
FDA Approves New Drug for Certain Types of Irritable Bowel Syndrome and …
FDA Approves New Drug for Certain Types of Irritable Bowel Syndrome and …
Filed under: drug treatment centers in st. louis mo
The U.S. Food and Drug Administration today approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat… Continue reading